Suvretta Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,125,112
Closed -$21M 75
2022
Q2
$21M Buy
+1,125,112
New +$21M 0.8% 42